Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, January 2005, p. 414-417, Vol. 49, No. 1
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.1.414-417.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
dfrA20, a Novel Trimethoprim Resistance Gene from Pasteurella multocida
Corinna Kehrenberg and
Stefan Schwarz*
Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft (FAL), Neustadt-Mariensee, Germany
Received 23 April 2004/
Returned for modification 16 July 2004/
Accepted 18 September 2004

ABSTRACT
A novel trimethoprim resistance gene, designated
dfrA20, was
detected on the 11-kb plasmid pCCK154 from
Pasteurella multocida.
The
dfrA20 gene codes for a dihydrofolate reductase of 169 amino
acids. Sequence comparisons revealed that the DfrA20 protein
differed distinctly from all dihydrofolate reductases known
so far.

TEXT
Trimethoprim (TMP) competitively inhibits the enzyme dihydrofolate
reductase, which is responsible for the reduction of dihydrofolate
to tetrahydrofolate (
6,
19). Bacterial resistance to trimethoprim
can be intrinsic or acquired. Intrinsic resistance by either
permeability barriers, folate auxotrophy, or dihydrofolate reductases
with low affinity for TMP have been detected in various bacterial
pathogens, including
Pseudomonas aeruginosa,
Clostridium spp.,
Brucella spp.,
Bacteroides spp., and
Enterococcus spp. (
15).
Different types of acquired TMP resistance, including mutations
in the promoter region or the dihydrofolate reductase structural
gene, have been reviewed by Sköld (
19). The most widespread
TMP resistance mechanism, namely, the replacement of a TMP-sensitive
dihydrofolate reductase by a plasmid-, transposon-, or cassette-borne
TMP-resistant dihydrofolate reductase, causes high-level TMP
resistance in various bacteria (
6,
19). Up to now, more than
25 different TMP resistance-mediating dihydrofolate reductase
(
dfr) genes, subdivided on the basis of their structure into
major types 1 and 2 (
14), which nowadays are referred to as
dfrA and
dfrB (
16), have been identified (
17,
19). Although
trimethoprim resistance is widespread among bacterial pathogens
from human and animal sources, previous attempts to identify
TMP resistance genes in bacteria of the genus
Pasteurella have
failed (
3). It was assumed that bacteria of the genera
Pasteurella and
Mannheimia may carry
dfrA or
dfrB genes different from those
previously identified in other gram-negative bacteria (
8). In
the present study, we describe a novel
dfr gene, designated
dfrA20, from
Pasteurella multocida.
P. multocida strain GB154 was obtained from the nasal swab specimen of a calf suffering from pneumonia. Antimicrobial susceptibility testing (13) revealed that the strain was resistant to ampicillin (MIC, 32 µg/ml), sulfamethoxazole (MIC, 1,024 µg/ml), and trimethoprim (MIC,
128 µg/ml). Strain GB154 harbored a plasmid of 11 kb, designated pCCK154, which upon transformation into Escherichia coli JM109 (Stratagene, Amsterdam, The Netherlands) and electrotransformation into the plasmid-free and antibiotic-susceptible P. multocida field isolate B130 (9) proved to mediate resistance to sulfamethoxazole and trimethoprim. MICs, determined by broth macrodilution (13), were 1,024 µg of sulfamethoxazole/ml and
128 µg of trimethoprim/ml in both recipient strains. PCR assays for the most frequently detected dfrA and dfrB genes of gram-negative bacteria as described by Frech et al. (4) confirmed that none of these genes was present on plasmid pCCK154. However, a sul2 gene, coding for a type II dihydropteroate synthase, was identified on this plasmid by PCR (4, 10). A restriction map of plasmid pCCK154 was constructed and served as a basis for cloning experiments. A ca. 1.9-kb PstI fragment was found to mediate trimethoprim resistance. This fragment plus another 0.7 kb upstream located on an EcoRV fragment of 5.6 kb and 1.2 kb downstream located on an EcoRV fragment of 5.4 kb were sequenced by primer walking (Fig. 1).
Sequence analysis of the ca. 3.8-kb segment revealed two stretches
of 99% sequence identity between pCCK154 and the
Vibrio salmonicida plasmid pRVS1 (GenBank accession number
AJ289135). These homologous
areas were from bases 293 to 1100 and 2179 to 3891 in the pCCK154
sequence (Fig.
1). The 1,078-bp sequence between these two pRVS1-homologous
regions contained the novel TMP resistance gene. The
dfrA20 gene was bracketed by the 3' end of a
thyA-like gene whose deduced
amino acid sequence showed 82% identity to the terminal 57 amino
acids of a thymidylate synthase from
Cytophaga hutchinsonii (accession number
ZP00117986) and the 5' end of a
topA-like
gene whose deduced amino acid sequence revealed 68% identity
to the initial 119 amino acids of a type IA topoisomerase from
C. hutchinsonii (accession number
ZP00118579). The organization
of a thymidylate synthase gene and a dihydrofolate reductase
gene in the same operon has been observed in a number of bacteria,
including, among others,
Bacillus subtilis (
7),
Bordetella bronchiseptica,
Bordetella parapertussis, and
Bordetella pertussis (accession
numbers
NC 002927 to
NC 002929). Both enzymes are essential
for DNA synthesis in that thymidylate synthase catalyzes the
transfer of a methyl group from
N5,
N10-methylentetrahydrofolate
to deoxyuridylate, thereby generating deoxythymidylate and 7,8-dihydrofolate,
whereas dihydrofolate reductase then converts 7,8-dihydrofolate
to tetrahydrofolate, a precursor of
N5,
N10-methylentetrahydrofolate.
At both junctions of pRVS1-homologous and -nonhomologous sequences
in pCCK154, the 6-bp direct repeat ATACGT was detected (Fig.
1). The sequence ATACGT is part of the phosphoglucosamine mutase
gene
glmM, which was disrupted in pCCK154 by the integration
of the
dfrA20-containing 1,078-bp segment (Fig.
1). Whether
these 6-bp direct repeats represent relics of a transposable
element that had been involved in the integration of the
dfrA20-containing
segment remains to be clarified. Bases 1 to 292 in the pCCK154
sequence did not reveal significant homology to sequences deposited
in the databases.
The sul2 gene was located in close proximity to the glmM gene in pCCK154 (Fig. 1). Its reading frame codes for a protein of 289 amino acids and thus represents the largest type II dihydropteroate synthase enzyme known to date. Previous studies showed that mutations in the terminal part of the sul2 reading frame might cause an extension of the reading frame without having an impact on the functioning of the enzyme (1, 10). In the present case, the loss of a single A at position 793 within the sul2 reading frame caused a frameshift mutation which led to the substitution of 6 codons and extended the reading frame by 18 codons compared to sul2 from pRVS1. The high MIC of sulfamethoxazole indicates that these alterations in the C terminus had no negative impact on sulfonamide resistance.
The dfrA20 gene isto the best of our knowledgethe first TMP resistance gene detected in P. multocida. Analysis of the flanking regions did not reveal structures resembling gene cassettes (16). The deduced DfrA20 protein sequence consists of 169 amino acids and thus is in the same size range (152 to 189 amino acids) as most of the bacterial DfrA proteins known so far. Phylogenetic analysis showed that DfrA20 from P. multocida represents a separate branch in the phylogenetic tree and clusters with Dfr proteins from gram-positive bacteria such as Staphylococcus, Bacillus, and Listeria (Fig. 2). Identities to the known DfrA proteins determined on the basis of a multisequence alignment varied between 20.0 and 37.7%, with the highest levels of identity to the Dfr proteins being found for Bacillus subtilis (37.7%) (7) and Staphylococcus haemolyticus (37.0%) (2). This observation confirmed that DfrA20 is only distantly related to other DfrA proteins. In addition to the DfrA proteins shown in Fig. 2, there are numerous reading frames which have been identified during whole-genome sequencing and are assumed to code for dihydrofolate reductases. Their functional annotation, however, was usually based only on Conserved Domain Database and Clusters of Orthologous Groups assignments, not on experimental proof of their role in TMP resistance.
In contrast to the situation with tetracycline resistance genes
(
11) and macrolide-lincosamide-streptogramin B resistance genes
(
18), there is still no accepted nomenclature for the
dfrA genes.
Hall and Partridge addressed this problem and suggested that
numbers should be assigned in the order of the database entries
(
5). Therefore, we tentatively designated the new
dfrA gene
from
P. multocida as
dfrA20. Since
dfrA20 is located on a small
plasmid that also carries the sulfonamide resistance gene
sul2,
there is potential for this gene to be disseminated horizontally
but also to be coselected by the use of sulfonamides. The origin
of the gene
dfrA20 remains to be answered. However, a lower
GC content (35%) of the 1,078-bp segment containing
dfrA20 than
of the whole genome of
P. multocida strain Pm70 (41%) (
12) suggested
that
dfrA20 is most likely not an indigenous
P. multocida gene.
Nucleotide sequence accession number.
The sequence of a 3,891-bp segment of plasmid pCCK154 has been deposited in the EMBL database under accession number AJ605332.

ACKNOWLEDGMENTS
We thank Vera Nöding for excellent technical assistance.

FOOTNOTES
* Corresponding author. Mailing address: Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft (FAL), Höltystr. 10, 31535 Neustadt-Mariensee, Germany. Phone: 49-5034-871-241. Fax: 49-5034-871-246. E-mail:
stefan.schwarz{at}fal.de.


REFERENCES
1 - Chang, Y. F., D. P. Ma, H. Q. Bai, R. Young, D. K. Struck, S. J. Shin, and D. H. Lein. 1992. Characterization of plasmids with antimicrobial resistant genes in Pasteurella haemolytica. DNA Seq. 3:89-97.[Medline]
2 - Dale, G. E., H. Langen, M. G. P. Page, R. L. Then, and D. Stüber. 1995. Cloning and characterization of a novel, plasmid-encoded trimethoprim-resistant dihydrofolate reductase from Staphylococcus haemolyticus MUR313. Antimicrob. Agents Chemother. 39:1920-1924.[Abstract]
3 - Escande, F., G. Gerbaud, J.-L. Martel, and P. Courvalin. 1991. Resistance to trimethoprim and 2,4-diamino-6,7-diisopropyl-pteridine (O/129) in Pasteurella haemolytica. Vet. Microbiol. 26:107-114.[CrossRef][Medline]
4 - Frech, G., C. Kehrenberg, and S. Schwarz. 2003. Resistance phenotypes and genotypes of multiresistant Salmonella enterica subsp. enterica serovar Typhimurium var. Copenhagen isolates from animal sources. J. Antimicrob. Chemother. 51:180-182.[Free Full Text]
5 - Hall, R., and S. Partridge. 2003. Unambiguous numbering of antibiotic resistance genes. Antimicrob. Agents Chemother. 47:3998.[Free Full Text]
6 - Huovinen, P., L. Sundström, G. Swedberg, and O. Sköld. 1995. Trimethoprim and sulfonamide resistance. Antimicrob. Agents Chemother. 39:279-289.[Free Full Text]
7 - Iwakura, M., M. Kawata, K. Tsuda, and T. Tanaka. 1988. Nucleotide sequence of the thymidylate synthase B and dihydrofolate reductase genes contained in one Bacillus subtilis operon. Gene 64:9-20.[CrossRef][Medline]
8 - Kehrenberg, C., G. Schulze-Tanzil, J.-L. Martel, E. Chaslus-Dancla, and S. Schwarz. 2001. Antimicrobial resistance in Pasteurella and Mannheimia: epidemiology and genetic basis. Vet. Res. 32:323-339.[CrossRef][Medline]
9 - Kehrenberg, C., and S. Schwarz. 2001. Molecular analysis of tetracycline resistance in Pasteurella aerogenes. Antimicrob. Agents Chemother. 45:2885-2890.[Abstract/Free Full Text]
10 - Kehrenberg, C., and S. Schwarz. 2001. Occurrence and linkage of genes coding for resistance to sulfonamides, streptomycin and chloramphenicol in bacteria of the genera Pasteurella and Mannheimia. FEMS Microbiol. Lett. 205:283-290.[CrossRef][Medline]
11 - Levy, S. B., L. M. McMurray, T. M. Barbosa, V. Burdett, P. Courvalin, W. Hillen, M. C. Roberts, J. I. Rood, and D. E. Taylor. 1999. Nomenclature for new tetracycline resistance determinants. Antimicrob. Agents Chemother. 43:1523-1524.[Abstract/Free Full Text]
12 - May, B. J., Q. Zhang, L. L. Li, M. L. Paustian, T. S. Whittam, and V. Kapur. 2001. Complete genomic sequence of Pasteurella multocida, Pm70. Proc. Natl. Acad. Sci. USA 98:3460-3465.[Abstract/Free Full Text]
13 - National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14 - Pattishall, K. H., J. Acar, J. J. Burchall, F. W. Goldstein, and R. J. Harvey. 1977. Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups. J. Biol. Chem. 252:2319-2323.[Abstract/Free Full Text]
15 - Quintiliani, R., Jr., D. F. Sahm, and P. Courvalin. 1999. Mechanisms of resistance to antimicrobial agents, p. 1505-1525. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
16 - Recchia, G. D., and R. M. Hall. 1995. Gene cassettes: a new class of mobile element. Microbiology 141:3015-3027.[Free Full Text]
17 - Roberts, M. C. 2002. Resistance to tetracycline, macrolide-lincosamide-streptogramin, trimethoprim, and sulfonamide drug classes. Mol. Biotechnol. 20:261-283.[CrossRef][Medline]
18 - Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.[Free Full Text]
19 - Sköld, O. 2001. Resistance to trimethoprim and sulfonamides. Vet. Res. 32:261-273.[CrossRef][Medline]
Antimicrobial Agents and Chemotherapy, January 2005, p. 414-417, Vol. 49, No. 1
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.1.414-417.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kehrenberg, C., Catry, B., Haesebrouck, F., de Kruif, A., Schwarz, S.
(2005). Novel Spectinomycin/Streptomycin Resistance Gene, aadA14, from Pasteurella multocida. Antimicrob. Agents Chemother.
49: 3046-3049
[Abstract]
[Full Text]
-
Doublet, B., Schwarz, S., Kehrenberg, C., Cloeckaert, A.
(2005). Florfenicol Resistance Gene floR Is Part of a Novel Transposon. Antimicrob. Agents Chemother.
49: 2106-2108
[Abstract]
[Full Text]